One recent analysis found that, over the course of three years, people taking semaglutide (the compound in Ozempic and the weight loss drug Wegovy) were about 40 to 70 percent less likely to be ...
Two new PET radiotracers have outperformed the only current Food and Drug Administration (FDA) approved radiotracer for ...
A delay in getting to the rapid eye movement (REM) stage of sleep may be linked to Alzheimer's disease and related dementias, ...
The Food and Drug Administration (FDA) has approved a new maintenance dosing schedule for Leqembi, a monoclonal antibody ...
An inert and unreactive gas may not seem like an obvious candidate for treating Alzheimer's disease, yet a new study in mice ...
Revolutionary nasal spray offers hope by potentially delaying Alzheimer's progression through cutting-edge neurological ...
No one is at their best 100 per cent of the time, but a significant personality change could be a sign of Alzheimer's disease ...
New guidelines will help doctors identify patients with a common memory-loss syndrome that is often misdiagnosed as Alzheimer's disease in older adults. The diagnostic criteria for limbic-predominant ...
Research shows that people who take these weight-loss medications may have a lower risk of dementia and numerous other health ...
New drug approvals and a federal dementia care pilot program among the year's significant developments, according to the ...
“Viral and bacterial infectious causes of common dementias have been proposed, supported by epidemiological data linking ...
Repurposing current drugs to tackle dementia is an ‘urgent priority’, academics say, but other experts warn more work is needed before they can be used to help treat the disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback